Desq Long
Sign in

Company

IONIS PHARMACEUTICALS INC

IONS · CIK 0000874015

SEC FORM 4
$2,307.56

IONIS PHARMACEUTICALS INC (IONS)

Sale of 53 shares at $43.5389 per share.

Reporting Person Swayze Eric · Officer Title EVP Research · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0000874015-26-000266 · filed 2026-10-19 · View filing →

SEC FORM 4
$59,081.88

IONIS PHARMACEUTICALS INC (IONS)

Sale of 1,357 shares at $43.5386 per share.

Reporting Person Devers Shannon L. · Officer Title EVP, Chief Human Resources Ofc · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0000874015-26-000267 · filed 2026-10-19 · View filing →

SEC FORM 4
$0.00

IONIS PHARMACEUTICALS INC (IONS)

Acquisition (code M) of 125 shares at $0.0 per share.

Reporting Person Swayze Eric · Officer Title EVP Research · Transaction Code M

Traded Oct 15, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0000874015-26-000266 · filed 2026-10-19 · View filing →

SEC FORM 4
$0.00

IONIS PHARMACEUTICALS INC (IONS)

Acquisition (code M) of 2,820 shares at $0.0 per share.

Reporting Person Devers Shannon L. · Officer Title EVP, Chief Human Resources Ofc · Transaction Code M

Traded Oct 15, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0000874015-26-000267 · filed 2026-10-19 · View filing →